<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01211795</url>
  </required_header>
  <id_info>
    <org_study_id>IND 79,629</org_study_id>
    <nct_id>NCT01211795</nct_id>
  </id_info>
  <brief_title>Topical Intra-Oral Ketoprofen for Migraine Prevention</brief_title>
  <official_title>Phase III Double Blind Randomized Placebo Controlled Trial Using 20% Intra-Oral Ketoprofen Gel for Migraine Prevention.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Behar, Caren, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Behar, Caren, M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intra-Oral Topical Ketoprofen gel, applied to a branch of the trigeminal nerve, has been
      shown to prevent migraines when used once daily for 3 months in open label studies. This is a
      randomized, double-blind, placebo controlled phase III prevention trial to determine safety
      and efficacy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 4 month trial. During the first month, a prospective headache diary is maintained.
      Migraine frequency, severity (1-10), duration, and all headache medications are recorded.

      Patients are then randomized to receive active gel or placebo gel in double blind fashion.

      Gel is applied to the posterior maxilla once daily for 3 months. A daily headache diary, as
      outlined above, is maintained throughout the trial. Patients may continue to take other
      migraine medications, as needed. No other new migraine therapies may be started during the
      trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in number of migraine days per month</measure>
    <time_frame>3 months</time_frame>
    <description>Number of migraine days per month will be compared before gel use and at the end of 3 months of use.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in migraine severity</measure>
    <time_frame>3 month total</time_frame>
    <description>Average migraine severity on a scale of 1-10, will be compared prior to gel use, and at the end of 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in migraine duration</measure>
    <time_frame>3 months</time_frame>
    <description>Average migraine duration will be compared prior to gel use, and at the end of 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in headache medication use</measure>
    <time_frame>3 months</time_frame>
    <description>Change in headache medication use will be compared prior to gel use, and at the end of 3 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>Topical Ketoprofen gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo gel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topical intraoral ketoprofen gel</intervention_name>
    <description>20% ketoprofen oral gel is applied once daily by cotton swab to a branch of the trigeminal nerve on the maxillary gingival mucosa above the 2nd and 3rd molars. The swab is held in place for 2 minutes at the same time once daily.</description>
    <arm_group_label>Topical Ketoprofen gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Gel</intervention_name>
    <description>An identical oral gel, without ketoprofen, or 'placebo gel' is applied using a cotton swab, once daily to a branch of the trigeminal nerve on the maxillary gingival mucosa. It is held in place for 2 minutes, once daily.</description>
    <arm_group_label>Placebo gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IHS Migraine with or without aura

          -  18 y.o. or older

          -  at least 4 migraines per month

        Exclusion Criteria:

          -  pregnancy

          -  other headache conditions

          -  chronic daily headache

          -  allergy or sensitivity to NSAIDs other severe illnesses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caren Behar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Medical College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Medical College</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2010</study_first_submitted>
  <study_first_submitted_qc>September 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2010</study_first_posted>
  <last_update_submitted>June 4, 2011</last_update_submitted>
  <last_update_submitted_qc>June 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>Caren Behar MD FACP</name_title>
    <organization>NYMC</organization>
  </responsible_party>
  <keyword>Migraine</keyword>
  <keyword>Prevention</keyword>
  <keyword>Treatment</keyword>
  <keyword>Ketoprofen</keyword>
  <keyword>Trigeminal nerve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketoprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

